IHC-plus(tm) PDE9A Antibody (Internal)

LifeSpan BioSciences

IHC-plus(tm) PDE9A Antibody (Internal)

23

Immunohistochemistry: The unconjugated form was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for the unconjugated form was determined to be 20 ug/ml.. IHC, IHC-P (20 µg/ml) Immunohistochemistry: The unconjugated form was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for the unconjugated form was determined to be 20 ug/ml.

ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

PDE9A

phosphodiesterase 9A

HSPDE9A2, high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, CGMP-specific 3',5'-cyclic phosphodiesterase type 9, phosphodiesterase PDE9A21

Rabbit

Canine, Human, Monkey

-20°C or -80°C,2°C to 8°C

41116161